The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
[3H-Benzothiazol-(2Z)-ylidene]-{2-[2-(3-chloro-phenyl)-ethylamino]-pyrimidin-4-yl}-acetonitrile ID: ALA425722
Max Phase: Preclinical
Molecular Formula: C21H16ClN5S
Molecular Weight: 405.91
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccc(Cl)c2)n1
Standard InChI: InChI=1S/C21H16ClN5S/c22-15-5-3-4-14(12-15)8-10-24-21-25-11-9-17(27-21)16(13-23)20-26-18-6-1-2-7-19(18)28-20/h1-7,9,11-12,26H,8,10H2,(H,24,25,27)/b20-16+
Standard InChI Key: IRJZMMMMXQUTQV-CAPFRKAQSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
1.4875 -2.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3125 -2.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9917 -1.7625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.9917 -3.1042 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.3125 -1.0125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7250 -1.7167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7167 -0.2917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7250 -3.1500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2042 -2.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2042 -2.8500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1375 -3.8625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5500 -0.2917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3042 0.4208 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5500 -1.7167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9625 -1.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1750 1.8333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0000 1.8333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4125 2.5458 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
0.2375 1.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4792 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5083 -1.6042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5083 -3.2625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9875 0.4000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0625 1.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4083 1.1208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1708 0.4083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2208 -2.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2208 -2.8500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 1 1 0
4 1 1 0
5 6 1 0
6 2 1 0
7 5 2 0
8 2 1 0
9 3 1 0
10 4 1 0
11 8 3 0
12 15 2 0
13 7 1 0
14 6 2 0
15 14 1 0
16 19 2 0
17 16 1 0
18 17 1 0
19 24 1 0
20 13 1 0
21 9 2 0
22 10 2 0
23 26 2 0
24 20 1 0
25 23 1 0
26 19 1 0
27 21 1 0
28 22 1 0
9 10 1 0
27 28 2 0
7 12 1 0
17 25 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 405.91Molecular Weight (Monoisotopic): 405.0815AlogP: 5.19#Rotatable Bonds: 5Polar Surface Area: 73.63Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 11.25CX Basic pKa: 2.59CX LogP: 5.08CX LogD: 5.08Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.57Np Likeness Score: -1.46
References 1. Gaillard P, Jeanclaude-Etter I, Ardissone V, Arkinstall S, Cambet Y, Camps M, Chabert C, Church D, Cirillo R, Gretener D, Halazy S, Nichols A, Szyndralewiez C, Vitte PA, Gotteland JP.. (2005) Design and synthesis of the first generation of novel potent, selective, and in vivo active (benzothiazol-2-yl)acetonitrile inhibitors of the c-Jun N-terminal kinase., 48 (14): [PMID:15999997 ] [10.1021/jm0310986 ]